Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by الشركة الأردنية لانتاج الأدويةfiledCriticalالشركة الأردنية لانتاج الأدوية
Priority to JO2005159ApriorityCriticalpatent/JO2440B1/en
Application grantedgrantedCritical
Publication of JO2440B1publicationCriticalpatent/JO2440B1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
The present invention is directed to a controlled-release pharmaceutical composition providing a sustained delivery of the basic drug Terbutaline sulfate, said composition comprising at least terbutaline sulfate or a derivative thereof as an active agent, and further comprising an inactive matrix, said matrix comprising a hydrophilic polysaccharide polymer mixture, said mixture comprising chitosan or a derivative thereof, and further comprising xanthan gum or a derivative thereof, wherein the ratio of xanthan gum and chitosan within said mixture is in the range from about 1:10 to about 10:1, and said coposition optionally comprising sodium bi-carbonate.
JO2005159A2005-10-232005-10-23Pharmaceutical polymer composition for oral controlled release delivery of terbutaline sulfate.
JO2440B1
(en)